Identification of a P53-dependent Pathway in the Induction of Apoptosis of Human Breast Cancer Cells by the Natural Product, Resveratrol
Overview
Affiliations
Objective: Resveratrol, a constituent found in grapes and various other plants, has been shown to have chemo-preventive activity against cancer, and specifically demonstrated to induce apoptosis by p53-dependent pathways in murine cells. The goal of this research was to identify the role of p53-dependent or p53-independent pathways in the induction of apoptosis in human breast cancer cells by this natural product.
Design: A number of human breast cancer cell lines, as well as a control of a wild-type line (astrocytoma N 1321N1), were investigated for induction of apoptosis by resveratrol using both microscopic evaluation and DNA fragmentation assays. Concurrently, we established the p53 gene status (wild-type or mutant) of each cell line by Western blot using p53-specific antibody.
Results: Apoptosis induced by resveratrol was found to occur only in breast cancer cells expressing wild-type p53 but not in mutant p53-expressing cells.
Conclusions: We therefore conclude that the natural product, resveratrol, induces apoptosis in breast cancer cells via p53-dependent pathways.
Utpal B, Bouenni H, Zehravi M, Sweilam S, Mortuza M, Arjun U Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40014131 DOI: 10.1007/s00210-025-03876-8.
Review on Natural Agents as Aromatase Inhibitors: Management of Breast Cancer.
Singh S Comb Chem High Throughput Screen. 2023; 27(18):2623-2638.
PMID: 37861041 DOI: 10.2174/0113862073269599231009115338.
Leischner C, Burkard M, Michel A, Berchtold S, Niessner H, Marongiu L Molecules. 2021; 26(18).
PMID: 34577057 PMC: 8466563. DOI: 10.3390/molecules26185586.
Transcriptome Analyses of the Anti-Proliferative Effects of 20(S)-Ginsenoside Rh2 on HepG2 Cells.
Zhang J, Li W, Yuan Q, Zhou J, Zhang J, Cao Y Front Pharmacol. 2019; 10:1331.
PMID: 31780945 PMC: 6855211. DOI: 10.3389/fphar.2019.01331.
The "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers.
Varghese E, Samuel S, Abotaleb M, Cheema S, Mamtani R, Busselberg D Cancers (Basel). 2018; 10(10).
PMID: 30248941 PMC: 6209965. DOI: 10.3390/cancers10100346.